C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I.

Autor: Reinisch, W.1 (AUTHOR), Wang, Y.2 (AUTHOR), Oddens, B. J.3 (AUTHOR), Link, R.4 (AUTHOR)
Zdroj: Alimentary Pharmacology & Therapeutics. Mar2012, Vol. 35 Issue 5, p568-576. 9p. 1 Diagram, 4 Charts, 2 Graphs.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje